NCT00526721已完成不适用
An Observational, Non-interventional, Multi-center Study to Evaluate Efficacy and Tolerability of High Dose Rosuvastatin in High Risk Patients After Titration
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 1,482
- 试验地点
- 1
研究概览
简要总结
To evaluate achievement ratio of treatment target goal in hypercholesterolemia patients with high risk after high dose rosuvastatin(20mg/day) titration
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •High-risk hyperlipidemia patients who are prescribed with rosuvastatin 10mg, based on the physician's clinical decision and fulfill the following criteria
- •Over 18 years of age
- •Have history of CHD or CHD risk equivalents, such as peripheral arterial disease, abdominal aortic aneurysm, symptomatic carotid artery disease (TIA or stroke of carotid origin or >50% obstruction of carotid artery), DM, and 2+ risk factors with 10-year risk CHD>20%
排除标准
- •Patients already taking other hyperlipidemic agents
- •Patients who do not fulfil the indication criteria for statin therapy
- •Patients who do not have baseline and/or follow-up lipid data to verify the efficacy data
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in KoreaDyslipidemiaNCT01372956AstraZeneca4,950
已完成
3 期
Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)HypercholesterolemiaNCT02476006Sanofi998
已完成
4 期
A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High CholesterolDyslipidemiasNCT00645151Pfizer's Upjohn has merged with Mylan to form Viatris Inc.512
招募中
4 期
Impact of Evolocumab as an Additional Lipid-lowering Therapy to Changes in Lipid Core Burden Index of Non-culprit Vulnerable Plaque in Patients Who Underwent Percutaneous Coronary Intervention for the Acute Coronary SyndromeClinical TrialAcute Coronary SyndromeNCT04719221Korea University Anam Hospital60
已完成
3 期
Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)HypercholesterolemiaNCT00418834Organon and Co1,053